Russell Investments Group’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-447
| Closed | -$417 | – | 3858 |
|
2024
Q4 | $417 | Sell |
447
-1,317
| -75% | -$1.23K | ﹤0.01% | 3628 |
|
2024
Q3 | $2.08K | Buy |
1,764
+166
| +10% | +$196 | ﹤0.01% | 3367 |
|
2024
Q2 | $1.23K | Buy |
+1,598
| New | +$1.23K | ﹤0.01% | 3413 |
|
2023
Q4 | – | Sell |
-57
| Closed | -$219 | – | 3282 |
|
2023
Q3 | $219 | Buy |
+57
| New | +$219 | ﹤0.01% | 3487 |
|
2023
Q2 | – | Sell |
-267,459
| Closed | -$690K | – | 3512 |
|
2023
Q1 | $690K | Sell |
267,459
-1,256
| -0.5% | -$3.24K | ﹤0.01% | 2142 |
|
2022
Q4 | $500K | Hold |
268,715
| – | – | ﹤0.01% | 2287 |
|
2022
Q3 | $492K | Buy |
268,715
+847
| +0.3% | +$1.55K | ﹤0.01% | 2251 |
|
2022
Q2 | $574K | Sell |
267,868
-8,105
| -3% | -$17.4K | ﹤0.01% | 2217 |
|
2022
Q1 | $865K | Sell |
275,973
-30,583
| -10% | -$95.9K | ﹤0.01% | 2023 |
|
2021
Q4 | $983K | Buy |
+306,556
| New | +$983K | ﹤0.01% | 2155 |
|
2021
Q2 | – | Sell |
-104,283
| Closed | -$419K | – | 3274 |
|
2021
Q1 | $419K | Buy |
+104,283
| New | +$419K | ﹤0.01% | 2594 |
|
2019
Q1 | – | Sell |
-500
| Closed | -$1K | – | 2988 |
|
2018
Q4 | $1K | Buy |
+500
| New | +$1K | ﹤0.01% | 2902 |
|